Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Working Capital/Sales

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.391.742.292.642.63

What is the latest Working Capital/Sales ratio of MEDICAMEN BIOTECH ?

The latest Working Capital/Sales ratio of MEDICAMEN BIOTECH is 2.39 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.39
Mar20231.74
Mar20222.29
Mar20212.64
Mar20202.63

How is Working Capital/Sales of MEDICAMEN BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2024 2.39
37.36
Mar2023 1.74
-24.02
Mar2022 2.29
-13.26
Mar2021 2.64
0.38
Mar2020 2.63 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Working Capital/Sales ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹650.5 Cr 9.3% 6.8% 1.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹163,010.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

9.3%

6.8%

1.1%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses